Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan
- PMID: 22959230
- DOI: 10.1016/j.jaad.2012.08.009
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan
Abstract
Background: The development of autoimmune sequelae is one of the characteristic features of drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome; however, the incidence of sequelae and prognosis of patients with DRESS are unknown.
Objective: We sought to investigate the incidence of sequelae, including less well-known sequelae, and long-term prognosis in patients with DRESS/drug-induced hypersensitivity syndrome.
Methods: A retrospective cohort study was conducted at a medical center in northern Taiwan using a DRESS/drug-induced hypersensitivity syndrome database. Patients who were followed up for at least 1 year were included in the study.
Results: Nine patients died before interview, whereas 43 patients completed a specially designed questionnaire. The overall cumulative incidence of long-term sequelae was 11.5% (6 of 52 patients). Four patients developed autoimmune diseases, specifically Graves disease (n = 2), type 1 diabetes mellitus (n = 1), and autoimmune hemolytic anemia (n = 1). Alopecia areata was also noted in 1 of the 2 patients with Graves disease. The other 2 patients developed renal failure after visceral involvement and required lifetime hemodialysis.
Limitations: Our study included a small number of patients. Further, viral studies were not performed.
Conclusion: The sequelae of DRESS can be divided into 2 major types that appear to occur in different age groups: young patients tend to develop autoimmune diseases, whereas elderly patients are more vulnerable to end-organ failure.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Comment in
-
Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms syndrome.J Am Acad Dermatol. 2013 Dec;69(6):1059-60. doi: 10.1016/j.jaad.2013.06.056. J Am Acad Dermatol. 2013. PMID: 24238171 No abstract available.
-
Reply to: "Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms".J Am Acad Dermatol. 2013 Dec;69(6):1060-2. doi: 10.1016/j.jaad.2013.08.026. J Am Acad Dermatol. 2013. PMID: 24238172 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
